Fig. 5
From: Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease
Comparison of chromatography obtained from LC–HR/MS analysis (left panel) and LC–MRM/MS analysis (right panel) of ApoC-III (ApoC-III-0) and its glycoforms (ApoC-III-1, ApoC-III-2) in human plasma. Reprinted with permission from [5]